General Biologicals Corp. Chairman & CEO Danner Lab Inc Chairman & CEO Pacgen Life Science Chairman & CEO CurieMed Corporation Chairman & CEO GB GENES CORP. Board director Taiwan Genomic Industry Alliance Inc. Board Director Ace Medical Technology Co., Ltd Board Director
CHLITINA Holding Limited. Chairman
Representative of Juristic Person of General Biologicals Corp.
General Biologicals Corp. General Manager Director of General Biologicals Corp. GB GENES CORP. Chairman Director of GB GENES CORP. Representative of Juristic Person of GB GENES CORP. Representative of Juristic Person of Viarich Biotechnology Co., Ltd
Academia Sinica Visiting Chair Professor NCKU Adjunct Professor Moderator of the Ministry of Science and Technolohy NTOU National Taiwan Ocean University Chair Professor Independent Director, PRIT Biotech Co. Ltd. Independent Director, General Biologicals Corp.
President, Glonova Co. Consultant, T-TOP Clinical Research Co. Director, Yolk Partners Co. Independent Director, General Biologicals Corp.
Steve, H. S. Kuo
The Ambassador-at-large of Taiwan Acer Medical Inc./Independent Director and Compensation Committee Independent Director, General Biologicals Corp.
What is GBC's main business?
GBC is a world-leading supplier of in vitro diagnostics and solutions, mainly engaged in the R&D, manufacturing, marketing and service of in vitro diagnostics. At present, the company's products cover three main areas: in vitro diagnostics, life science (Life Science) and services, drugs and biological consumer products, and has the most complete product line in the same industry in China. The company's products and solutions have been used in more than 40 countries and regions around the world.
How big is the company now?
In 2021, the company has 120 employees worldwide.
How can I access the company's financial statements?
The electronic version of the company's financial report can be accessed on the website of the Public Information Observatory (https://mops.twse.com.tw) by entering the company code "4117" to view relevant information.
GBC was founded in 1984 by the Taiwan Government to develop the first In-vitro Diagnostic (IVD) HBV kit using RIA-based technology as part of Taiwan's nationwide Liver Disease Prevention Program.
GBC has since started researching and developing Hepatitis and Retrovirus (HIV) across various platforms — from RIA, ELISA (Immunoassay) and Real-Time PCR (Molecular) to CTC (Circulating Tumor Cell).
With an expanding range of products including Tumor markers, Fertility, Torch, and Thyroid tests, GBC now has two R&D Centers (Hsin Chu, Taiwan and San Diego, USA) as well as a sales and marketing office in China.
The company has also entered the consumable products market with their brand ‘oh care’ — a range of oral care products for infants and adults that uses the P113 peptide ingredient.